Matches in SemOpenAlex for { <https://semopenalex.org/work/W3150929668> ?p ?o ?g. }
- W3150929668 endingPage "1952" @default.
- W3150929668 startingPage "1952" @default.
- W3150929668 abstract "Angiogenesis inhibition is a key step towards the designing of new chemotherapeutic agents. In a view to preparing new molecular entities for cancer treatment, eighteen 1,2,3-triazole-uracil ensembles 5a–r were designed and synthesized via the click reaction. The ligands were well characterized using 1H-, 13C-NMR, elemental analysis and ESI-mass spectrometry. The in silico binding propinquities of the ligands were studied sequentially in the active region of VEGFR-2 using the Molegro virtual docker. All the compounds produced remarkable interactions and potentially inhibitory ligands against VEGFR-2 were obtained with high negative binding energies. Drug-likeness was assessed from the ADME properties. Cytotoxicity of the test compounds was measured against HeLa and HUH-7 tumor cells and NIH/3T3 normal cells by MTT assay. Compound 5h showed higher growth inhibition activity than the positive control, 5-fluorouracil (5-FU), against both HeLa and HUH-7 cells with IC50 values of 4.5 and 7.7 μM respectively. Interestingly, the compounds 5a–r did not show any cytotoxicity towards the normal cell lines. The results advance the position of substituted triazoles in the area of drug design with no ambiguity." @default.
- W3150929668 created "2021-04-13" @default.
- W3150929668 creator A5031705374 @default.
- W3150929668 creator A5034954547 @default.
- W3150929668 creator A5042101373 @default.
- W3150929668 creator A5048877183 @default.
- W3150929668 creator A5052279353 @default.
- W3150929668 creator A5068089112 @default.
- W3150929668 creator A5068132244 @default.
- W3150929668 creator A5075961900 @default.
- W3150929668 creator A5087763956 @default.
- W3150929668 creator A5084735113 @default.
- W3150929668 date "2021-03-30" @default.
- W3150929668 modified "2023-10-14" @default.
- W3150929668 title "Synthesis and Rational Design of New Appended 1,2,3-Triazole-uracil Ensembles as Promising Anti-Tumor Agents via In Silico VEGFR-2 Transferase Inhibition" @default.
- W3150929668 cites W1514855609 @default.
- W3150929668 cites W191227402 @default.
- W3150929668 cites W1982998720 @default.
- W3150929668 cites W1990095055 @default.
- W3150929668 cites W1994193851 @default.
- W3150929668 cites W2000542942 @default.
- W3150929668 cites W2015196214 @default.
- W3150929668 cites W2033495141 @default.
- W3150929668 cites W2034551557 @default.
- W3150929668 cites W2043668344 @default.
- W3150929668 cites W2043855224 @default.
- W3150929668 cites W2075655589 @default.
- W3150929668 cites W2084740377 @default.
- W3150929668 cites W2085565086 @default.
- W3150929668 cites W2097603783 @default.
- W3150929668 cites W2097604487 @default.
- W3150929668 cites W2113443131 @default.
- W3150929668 cites W2117692326 @default.
- W3150929668 cites W2121265439 @default.
- W3150929668 cites W2132262459 @default.
- W3150929668 cites W2161836547 @default.
- W3150929668 cites W2163403599 @default.
- W3150929668 cites W2171074980 @default.
- W3150929668 cites W2286433349 @default.
- W3150929668 cites W2482715573 @default.
- W3150929668 cites W2509939235 @default.
- W3150929668 cites W2520518799 @default.
- W3150929668 cites W2577017727 @default.
- W3150929668 cites W2598230851 @default.
- W3150929668 cites W2766979556 @default.
- W3150929668 cites W2769328077 @default.
- W3150929668 cites W2782344500 @default.
- W3150929668 cites W2785579854 @default.
- W3150929668 cites W2789766205 @default.
- W3150929668 cites W2807910699 @default.
- W3150929668 cites W2921110122 @default.
- W3150929668 cites W2947247809 @default.
- W3150929668 cites W2954100438 @default.
- W3150929668 cites W2974793213 @default.
- W3150929668 cites W2988361120 @default.
- W3150929668 cites W3002443851 @default.
- W3150929668 cites W3003025448 @default.
- W3150929668 cites W3006185147 @default.
- W3150929668 cites W3023262441 @default.
- W3150929668 cites W3024712524 @default.
- W3150929668 cites W3034131973 @default.
- W3150929668 cites W3039947924 @default.
- W3150929668 cites W3080745443 @default.
- W3150929668 cites W3093344784 @default.
- W3150929668 cites W3096002562 @default.
- W3150929668 cites W3103854394 @default.
- W3150929668 cites W3112436986 @default.
- W3150929668 cites W3117137135 @default.
- W3150929668 cites W3122976576 @default.
- W3150929668 cites W4248107770 @default.
- W3150929668 doi "https://doi.org/10.3390/molecules26071952" @default.
- W3150929668 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8037033" @default.
- W3150929668 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33808444" @default.
- W3150929668 hasPublicationYear "2021" @default.
- W3150929668 type Work @default.
- W3150929668 sameAs 3150929668 @default.
- W3150929668 citedByCount "4" @default.
- W3150929668 countsByYear W31509296682021 @default.
- W3150929668 countsByYear W31509296682022 @default.
- W3150929668 countsByYear W31509296682023 @default.
- W3150929668 crossrefType "journal-article" @default.
- W3150929668 hasAuthorship W3150929668A5031705374 @default.
- W3150929668 hasAuthorship W3150929668A5034954547 @default.
- W3150929668 hasAuthorship W3150929668A5042101373 @default.
- W3150929668 hasAuthorship W3150929668A5048877183 @default.
- W3150929668 hasAuthorship W3150929668A5052279353 @default.
- W3150929668 hasAuthorship W3150929668A5068089112 @default.
- W3150929668 hasAuthorship W3150929668A5068132244 @default.
- W3150929668 hasAuthorship W3150929668A5075961900 @default.
- W3150929668 hasAuthorship W3150929668A5084735113 @default.
- W3150929668 hasAuthorship W3150929668A5087763956 @default.
- W3150929668 hasBestOaLocation W31509296681 @default.
- W3150929668 hasConcept C104317684 @default.
- W3150929668 hasConcept C109316439 @default.
- W3150929668 hasConcept C178790620 @default.
- W3150929668 hasConcept C185592680 @default.
- W3150929668 hasConcept C202751555 @default.
- W3150929668 hasConcept C21951064 @default.